350 related articles for article (PubMed ID: 34067472)
1. Harnessing the Physiological Functions of Cellular Prion Protein in the Kidneys: Applications for Treating Renal Diseases.
Yoon S; Go G; Yoon Y; Lim J; Lee G; Lee S
Biomolecules; 2021 May; 11(6):. PubMed ID: 34067472
[TBL] [Abstract][Full Text] [Related]
2. The Cellular Prion Protein: A Promising Therapeutic Target for Cancer.
Go G; Lee SH
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276687
[TBL] [Abstract][Full Text] [Related]
3. The cellular prion protein (PrP(C)): its physiological function and role in disease.
Westergard L; Christensen HM; Harris DA
Biochim Biophys Acta; 2007 Jun; 1772(6):629-44. PubMed ID: 17451912
[TBL] [Abstract][Full Text] [Related]
4. Alkylating antitumor drug mechlorethamine conceals a structured PrP domain and inhibits in vitro prion amplification.
Zhou X; Bi H; Wong J; Shimoji M; Wang Y; Yuan J; Xiao X; Wang GX; Zou WQ
J Toxicol Environ Health A; 2011; 74(22-24):1493-503. PubMed ID: 22043910
[TBL] [Abstract][Full Text] [Related]
5. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
Gilch S; Nunziante M; Ertmer A; Schätzl HM
Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
[TBL] [Abstract][Full Text] [Related]
6. Strain specificity and drug resistance in anti-prion therapy.
Miller-Vedam L; Ghaemmaghami S
Curr Top Med Chem; 2013; 13(19):2397-406. PubMed ID: 24059341
[TBL] [Abstract][Full Text] [Related]
7. TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrP
Yoon YM; Kim S; Han YS; Yun CW; Lee JH; Noh H; Lee SH
Redox Biol; 2019 Apr; 22():101144. PubMed ID: 30785084
[TBL] [Abstract][Full Text] [Related]
8. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
9. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
10. The prion protein in neuroimmune crosstalk.
Salvesen Ø; Tatzelt J; Tranulis MA
Neurochem Int; 2019 Nov; 130():104335. PubMed ID: 30448564
[TBL] [Abstract][Full Text] [Related]
11. Distribution of the cellular prion protein (PrPC) in brains of livestock and domesticated species.
Díaz-San Segundo F; Salguero FJ; de Avila A; Espinosa JC; Torres JM; Brun A
Acta Neuropathol; 2006 Nov; 112(5):587-95. PubMed ID: 16957924
[TBL] [Abstract][Full Text] [Related]
12. Trapping prion protein in the endoplasmic reticulum impairs PrPC maturation and prevents PrPSc accumulation.
Cardinale A; Filesi I; Vetrugno V; Pocchiari M; Sy MS; Biocca S
J Biol Chem; 2005 Jan; 280(1):685-94. PubMed ID: 15513919
[TBL] [Abstract][Full Text] [Related]
13. Oral Prion Neuroinvasion Occurs Independently of PrP
Marshall A; Bradford BM; Clarke AR; Manson JC; Mabbott NA
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021891
[TBL] [Abstract][Full Text] [Related]
14. Cellular prion protein is present in mitochondria of healthy mice.
Faris R; Moore RA; Ward A; Race B; Dorward DW; Hollister JR; Fischer ER; Priola SA
Sci Rep; 2017 Feb; 7():41556. PubMed ID: 28148964
[TBL] [Abstract][Full Text] [Related]
15. A New Take on Prion Protein Dynamics in Cellular Trafficking.
Alves RN; Iglesia RP; Prado MB; Melo Escobar MI; Boccacino JM; Fernandes CFL; Coelho BP; Fortes AC; Lopes MH
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092231
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
Jeong JK; Seo JS; Moon MH; Lee YJ; Seol JW; Park SY
Neurobiol Aging; 2012 May; 33(5):1006.e1-10. PubMed ID: 22036844
[TBL] [Abstract][Full Text] [Related]
17. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
18. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
[TBL] [Abstract][Full Text] [Related]
20. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
Iraci N; Stincardini C; Barreca ML; Biasini E
Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
